[1] Dhawan A, Puppi J, Hughes RD, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol,2010,7:288-298.
[2] Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology,2010,51:297-305.
[3] Prior N, Inacio P, Huch M. Liver organoids: from basic research to therapeutic applications. Gut,2019,68:2228-2237.
[4] Huang P, Zhang L, Gao Y, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell,2014,14:370-384.
[5] Zhang K, Zhang L, Liu W, et al. In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity. Cell Stem Cell,2018,23:806-819.e804.
[6] Sun T, Annunziato S, Bergling S, et al. ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation. Cell Stem Cell,2021,28:1822-1837.e1810.
[7] Krohn N, Kapoor S, Enami Y, et al. Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells. Gastroenterology, 2009,136:1806-1817.
[8] Wang C, Zhang L, Sun Z, et al. Dedifferentiation-associated inflammatory factors of long-term expanded human hepatocytes exacerbate their elimination by macrophages during liver engraftment. Hepatology,2022,76:1690-1705.
[9] Azuma H, Paulk N, Ranade A, et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice. Nat Biotechnol,2007,25:903-910.
[10] Han X, Wang M, Duan S, et al. Generation of hypoimmunogenic human pluripotent stem cells. Proc Natl Acad Sci U S A,2019,116:10441-10446.
[11] Loft A, Alfaro AJ, Schmidt SF, et al. Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. Cell Metab,2021,33:1685-1700.e1689. |
